Question 1

What is the catalog number for HIV-1 Envelope Recombinant (HIV-1 Envelope)?

Accepted Answer

The catalog number for HIV-1 Envelope Recombinant (HIV-1 Envelope) is PT_40961.

Question 2

What sizes are available for HIV-1 Envelope Recombinant (HIV-1 Envelope)?

Accepted Answer

HIV-1 Envelope Recombinant (HIV-1 Envelope) is available in the following size(s): 100 µg, 500 µg, 1000 µg.

Question 3

How many pack sizes does HIV-1 Envelope Recombinant (HIV-1 Envelope) come in?

Accepted Answer

HIV-1 Envelope Recombinant (HIV-1 Envelope) is available in 3 different pack sizes.

Question 4

Is HIV-1 Envelope Recombinant (HIV-1 Envelope) in stock?

Accepted Answer

HIV-1 Envelope Recombinant (HIV-1 Envelope) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 7

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

HIV-1 Envelope Recombinant (HIV-1 Envelope)

Product Specifications

Type

Available Sizes

Frequently Asked Questions

Explore Other Products

Ki-67 (Proliferating Cell Marker) (MKI67/2465), CF594 conjugate, 0.1mg/mL

Ly6g Rat Monoclonal Antibody [Clone ID: RB6-8C5]

RAB5B (NM_002868) Human Over-expression Lysate

Tissue FFPE Sections, Breast

ReadiUse™ Preactivated PE-Cy5.5 Tandem

ERCC1 / RAD10 (Tumor Progression Marker) (ERCC1/2318), CF640R conjugate, 0.1mg/mL